Patient
SITE005-0020
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE005 (FRA) (Dr. Muller)
consented 2025-09-21
Adverse events
6
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 6
Grade 1 Anaemia — outcome: RECOVERED/RESOLVED; onset 2023-02-24 (study day 335); relationship: NOT RELATED
Grade 2 Constipation — outcome: RECOVERED/RESOLVED; onset 2023-01-25 (study day 305); relationship: not assessed
Grade 1 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2022-11-25 (study day 244); relationship: not assessed
Grade 2 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2022-11-02 (study day 221); relationship: not assessed
Grade 2 Anaemia — outcome: RECOVERED/RESOLVED; onset 2022-06-04 (study day 70); relationship: NOT RELATED
Grade 1 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2022-04-09 (study day 14); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.